世界のmRNA治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global mRNA Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3937
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、mRNA治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ワクチン、治療薬）、用途別市場規模（たんぱく質病、遺伝子機能障害、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・mRNA治療の市場動向
・企業の競争状況、市場シェア
・mRNA治療の種類別市場規模（ワクチン、治療薬）
・mRNA治療の用途別市場規模（たんぱく質病、遺伝子機能障害、その他）
・mRNA治療の北米市場規模2016-2027（アメリカ、カナダ）
・mRNA治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・mRNA治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・mRNA治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・mRNA治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（CureVac、Moderna、BioNTech (Pfizer)、Sanofi (Translate Bio)、Ethris (AstraZeneca)、Kernal Biologics、RaNA Therapeutics、Silence Therapeutics）
・結論

By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for specific therapeutic application. mRNA holds the potential to revolutionize vaccination, protein replacement therapies, and the treatment of genetic diseases.

Market Analysis and Insights: Global mRNA Treatment Market
The global mRNA Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global mRNA Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global mRNA Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global mRNA Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global mRNA Treatment market.

Global mRNA Treatment Scope and Market Size
mRNA Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global mRNA Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Vaccine
Drugs

Segment by Application
Protein Diseases
Gene Dysfunction Diseases
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
CureVac
Moderna
BioNTech (Pfizer)
Sanofi (Translate Bio)
Ethris (AstraZeneca)
Kernal Biologics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Vaccine
1.2.3 Drugs
1.3 Market by Application
1.3.1 Global mRNA Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Protein Diseases
1.3.3 Gene Dysfunction Diseases
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global mRNA Treatment Market Perspective (2016-2027)
2.2 mRNA Treatment Growth Trends by Regions
2.2.1 mRNA Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 mRNA Treatment Historic Market Share by Regions (2016-2021)
2.2.3 mRNA Treatment Forecasted Market Size by Regions (2022-2027)
2.3 mRNA Treatment Industry Dynamic
2.3.1 mRNA Treatment Market Trends
2.3.2 mRNA Treatment Market Drivers
2.3.3 mRNA Treatment Market Challenges
2.3.4 mRNA Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top mRNA Treatment Players by Revenue
3.1.1 Global Top mRNA Treatment Players by Revenue (2016-2021)
3.1.2 Global mRNA Treatment Revenue Market Share by Players (2016-2021)
3.2 Global mRNA Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by mRNA Treatment Revenue
3.4 Global mRNA Treatment Market Concentration Ratio
3.4.1 Global mRNA Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Treatment Revenue in 2020
3.5 mRNA Treatment Key Players Head office and Area Served
3.6 Key Players mRNA Treatment Product Solution and Service
3.7 Date of Enter into mRNA Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 mRNA Treatment Breakdown Data by Type
4.1 Global mRNA Treatment Historic Market Size by Type (2016-2021)
4.2 Global mRNA Treatment Forecasted Market Size by Type (2022-2027)

5 mRNA Treatment Breakdown Data by Application
5.1 Global mRNA Treatment Historic Market Size by Application (2016-2021)
5.2 Global mRNA Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America mRNA Treatment Market Size (2016-2027)
6.2 North America mRNA Treatment Market Size by Type
6.2.1 North America mRNA Treatment Market Size by Type (2016-2021)
6.2.2 North America mRNA Treatment Market Size by Type (2022-2027)
6.2.3 North America mRNA Treatment Market Size by Type (2016-2027)
6.3 North America mRNA Treatment Market Size by Application
6.3.1 North America mRNA Treatment Market Size by Application (2016-2021)
6.3.2 North America mRNA Treatment Market Size by Application (2022-2027)
6.3.3 North America mRNA Treatment Market Size by Application (2016-2027)
6.4 North America mRNA Treatment Market Size by Country
6.4.1 North America mRNA Treatment Market Size by Country (2016-2021)
6.4.2 North America mRNA Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe mRNA Treatment Market Size (2016-2027)
7.2 Europe mRNA Treatment Market Size by Type
7.2.1 Europe mRNA Treatment Market Size by Type (2016-2021)
7.2.2 Europe mRNA Treatment Market Size by Type (2022-2027)
7.2.3 Europe mRNA Treatment Market Size by Type (2016-2027)
7.3 Europe mRNA Treatment Market Size by Application
7.3.1 Europe mRNA Treatment Market Size by Application (2016-2021)
7.3.2 Europe mRNA Treatment Market Size by Application (2022-2027)
7.3.3 Europe mRNA Treatment Market Size by Application (2016-2027)
7.4 Europe mRNA Treatment Market Size by Country
7.4.1 Europe mRNA Treatment Market Size by Country (2016-2021)
7.4.2 Europe mRNA Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific mRNA Treatment Market Size (2016-2027)
8.2 Asia-Pacific mRNA Treatment Market Size by Type
8.2.1 Asia-Pacific mRNA Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific mRNA Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific mRNA Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific mRNA Treatment Market Size by Application
8.3.1 Asia-Pacific mRNA Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific mRNA Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific mRNA Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific mRNA Treatment Market Size by Region
8.4.1 Asia-Pacific mRNA Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific mRNA Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America mRNA Treatment Market Size (2016-2027)
9.2 Latin America mRNA Treatment Market Size by Type
9.2.1 Latin America mRNA Treatment Market Size by Type (2016-2021)
9.2.2 Latin America mRNA Treatment Market Size by Type (2022-2027)
9.2.3 Latin America mRNA Treatment Market Size by Type (2016-2027)
9.3 Latin America mRNA Treatment Market Size by Application
9.3.1 Latin America mRNA Treatment Market Size by Application (2016-2021)
9.3.2 Latin America mRNA Treatment Market Size by Application (2022-2027)
9.3.3 Latin America mRNA Treatment Market Size by Application (2016-2027)
9.4 Latin America mRNA Treatment Market Size by Country
9.4.1 Latin America mRNA Treatment Market Size by Country (2016-2021)
9.4.2 Latin America mRNA Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa mRNA Treatment Market Size (2016-2027)
10.2 Middle East & Africa mRNA Treatment Market Size by Type
10.2.1 Middle East & Africa mRNA Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa mRNA Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa mRNA Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa mRNA Treatment Market Size by Application
10.3.1 Middle East & Africa mRNA Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa mRNA Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa mRNA Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa mRNA Treatment Market Size by Country
10.4.1 Middle East & Africa mRNA Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa mRNA Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 CureVac
11.1.1 CureVac Company Details
11.1.2 CureVac Business Overview
11.1.3 CureVac mRNA Treatment Introduction
11.1.4 CureVac Revenue in mRNA Treatment Business (2016-2021)
11.1.5 CureVac Recent Development
11.2 Moderna
11.2.1 Moderna Company Details
11.2.2 Moderna Business Overview
11.2.3 Moderna mRNA Treatment Introduction
11.2.4 Moderna Revenue in mRNA Treatment Business (2016-2021)
11.2.5 Moderna Recent Development
11.3 BioNTech (Pfizer)
11.3.1 BioNTech (Pfizer) Company Details
11.3.2 BioNTech (Pfizer) Business Overview
11.3.3 BioNTech (Pfizer) mRNA Treatment Introduction
11.3.4 BioNTech (Pfizer) Revenue in mRNA Treatment Business (2016-2021)
11.3.5 BioNTech (Pfizer) Recent Development
11.4 Sanofi (Translate Bio)
11.4.1 Sanofi (Translate Bio) Company Details
11.4.2 Sanofi (Translate Bio) Business Overview
11.4.3 Sanofi (Translate Bio) mRNA Treatment Introduction
11.4.4 Sanofi (Translate Bio) Revenue in mRNA Treatment Business (2016-2021)
11.4.5 Sanofi (Translate Bio) Recent Development
11.5 Ethris (AstraZeneca)
11.5.1 Ethris (AstraZeneca) Company Details
11.5.2 Ethris (AstraZeneca) Business Overview
11.5.3 Ethris (AstraZeneca) mRNA Treatment Introduction
11.5.4 Ethris (AstraZeneca) Revenue in mRNA Treatment Business (2016-2021)
11.5.5 Ethris (AstraZeneca) Recent Development
11.6 Kernal Biologics
11.6.1 Kernal Biologics Company Details
11.6.2 Kernal Biologics Business Overview
11.6.3 Kernal Biologics mRNA Treatment Introduction
11.6.4 Kernal Biologics Revenue in mRNA Treatment Business (2016-2021)
11.6.5 Kernal Biologics Recent Development
11.7 RaNA Therapeutics
11.7.1 RaNA Therapeutics Company Details
11.7.2 RaNA Therapeutics Business Overview
11.7.3 RaNA Therapeutics mRNA Treatment Introduction
11.7.4 RaNA Therapeutics Revenue in mRNA Treatment Business (2016-2021)
11.7.5 RaNA Therapeutics Recent Development
11.8 Silence Therapeutics
11.8.1 Silence Therapeutics Company Details
11.8.2 Silence Therapeutics Business Overview
11.8.3 Silence Therapeutics mRNA Treatment Introduction
11.8.4 Silence Therapeutics Revenue in mRNA Treatment Business (2016-2021)
11.8.5 Silence Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global mRNA Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Vaccine
Table 3. Key Players of Drugs
Table 4. Global mRNA Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global mRNA Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global mRNA Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global mRNA Treatment Market Share by Regions (2016-2021)
Table 8. Global mRNA Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global mRNA Treatment Market Share by Regions (2022-2027)
Table 10. mRNA Treatment Market Trends
Table 11. mRNA Treatment Market Drivers
Table 12. mRNA Treatment Market Challenges
Table 13. mRNA Treatment Market Restraints
Table 14. Global mRNA Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global mRNA Treatment Market Share by Players (2016-2021)
Table 16. Global Top mRNA Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Treatment as of 2020)
Table 17. Ranking of Global Top mRNA Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by mRNA Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players mRNA Treatment Product Solution and Service
Table 21. Date of Enter into mRNA Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global mRNA Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global mRNA Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global mRNA Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global mRNA Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global mRNA Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global mRNA Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global mRNA Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global mRNA Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America mRNA Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America mRNA Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America mRNA Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America mRNA Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America mRNA Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America mRNA Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe mRNA Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe mRNA Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe mRNA Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe mRNA Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe mRNA Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe mRNA Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific mRNA Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific mRNA Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific mRNA Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific mRNA Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific mRNA Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific mRNA Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America mRNA Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America mRNA Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America mRNA Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America mRNA Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America mRNA Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America mRNA Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa mRNA Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa mRNA Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa mRNA Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa mRNA Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa mRNA Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa mRNA Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. CureVac Company Details
Table 62. CureVac Business Overview
Table 63. CureVac mRNA Treatment Product
Table 64. CureVac Revenue in mRNA Treatment Business (2016-2021) & (US$ Million)
Table 65. CureVac Recent Development
Table 66. Moderna Company Details
Table 67. Moderna Business Overview
Table 68. Moderna mRNA Treatment Product
Table 69. Moderna Revenue in mRNA Treatment Business (2016-2021) & (US$ Million)
Table 70. Moderna Recent Development
Table 71. BioNTech (Pfizer) Company Details
Table 72. BioNTech (Pfizer) Business Overview
Table 73. BioNTech (Pfizer) mRNA Treatment Product
Table 74. BioNTech (Pfizer) Revenue in mRNA Treatment Business (2016-2021) & (US$ Million)
Table 75. BioNTech (Pfizer) Recent Development
Table 76. Sanofi (Translate Bio) Company Details
Table 77. Sanofi (Translate Bio) Business Overview
Table 78. Sanofi (Translate Bio) mRNA Treatment Product
Table 79. Sanofi (Translate Bio) Revenue in mRNA Treatment Business (2016-2021) & (US$ Million)
Table 80. Sanofi (Translate Bio) Recent Development
Table 81. Ethris (AstraZeneca) Company Details
Table 82. Ethris (AstraZeneca) Business Overview
Table 83. Ethris (AstraZeneca) mRNA Treatment Product
Table 84. Ethris (AstraZeneca) Revenue in mRNA Treatment Business (2016-2021) & (US$ Million)
Table 85. Ethris (AstraZeneca) Recent Development
Table 86. Kernal Biologics Company Details
Table 87. Kernal Biologics Business Overview
Table 88. Kernal Biologics mRNA Treatment Product
Table 89. Kernal Biologics Revenue in mRNA Treatment Business (2016-2021) & (US$ Million)
Table 90. Kernal Biologics Recent Development
Table 91. RaNA Therapeutics Company Details
Table 92. RaNA Therapeutics Business Overview
Table 93. RaNA Therapeutics mRNA Treatment Product
Table 94. RaNA Therapeutics Revenue in mRNA Treatment Business (2016-2021) & (US$ Million)
Table 95. RaNA Therapeutics Recent Development
Table 96. Silence Therapeutics Company Details
Table 97. Silence Therapeutics Business Overview
Table 98. Silence Therapeutics Revenue in mRNA Treatment Business (2016-2021) & (US$ Million)
Table 99. Silence Therapeutics Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global mRNA Treatment Market Share by Type: 2020 VS 2027
Figure 2. Vaccine Features
Figure 3. Drugs Features
Figure 4. Global mRNA Treatment Market Share by Application: 2020 VS 2027
Figure 5. Protein Diseases Case Studies
Figure 6. Gene Dysfunction Diseases Case Studies
Figure 7. Others Case Studies
Figure 8. mRNA Treatment Report Years Considered
Figure 9. Global mRNA Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global mRNA Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global mRNA Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global mRNA Treatment Market Share by Regions (2022-2027)
Figure 13. Global mRNA Treatment Market Share by Players in 2020
Figure 14. Global Top mRNA Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by mRNA Treatment Revenue in 2020
Figure 16. Global mRNA Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global mRNA Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America mRNA Treatment Market Share by Type (2016-2027)
Figure 20. North America mRNA Treatment Market Share by Application (2016-2027)
Figure 21. North America mRNA Treatment Market Share by Country (2016-2027)
Figure 22. United States mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe mRNA Treatment Market Share by Type (2016-2027)
Figure 26. Europe mRNA Treatment Market Share by Application (2016-2027)
Figure 27. Europe mRNA Treatment Market Share by Country (2016-2027)
Figure 28. Germany mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific mRNA Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific mRNA Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific mRNA Treatment Market Share by Region (2016-2027)
Figure 38. China mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America mRNA Treatment Market Share by Type (2016-2027)
Figure 46. Latin America mRNA Treatment Market Share by Application (2016-2027)
Figure 47. Latin America mRNA Treatment Market Share by Country (2016-2027)
Figure 48. Mexico mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa mRNA Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa mRNA Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa mRNA Treatment Market Share by Country (2016-2027)
Figure 54. Turkey mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE mRNA Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. CureVac Revenue Growth Rate in mRNA Treatment Business (2016-2021)
Figure 58. Moderna Revenue Growth Rate in mRNA Treatment Business (2016-2021)
Figure 59. BioNTech (Pfizer) Revenue Growth Rate in mRNA Treatment Business (2016-2021)
Figure 60. Sanofi (Translate Bio) Revenue Growth Rate in mRNA Treatment Business (2016-2021)
Figure 61. Ethris (AstraZeneca) Revenue Growth Rate in mRNA Treatment Business (2016-2021)
Figure 62. Kernal Biologics Revenue Growth Rate in mRNA Treatment Business (2016-2021)
Figure 63. RaNA Therapeutics Revenue Growth Rate in mRNA Treatment Business (2016-2021)
Figure 64. Silence Therapeutics Revenue Growth Rate in mRNA Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界のmRNA治療市場規模・現状・予測（2021年-2027年）

Global mRNA Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3937 2021年4月 92Pages
QYResearch社発行の本調査資料では、mRNA治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ワクチン、治療薬）、用途別市場規模（たんぱく質病、遺伝子機能障害、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界のmRNAがんワクチン・治療薬市場規模・現状・予測（2021年-2027年）

Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z3935 2021年4月 92Pages
QYResearch社発行の本調査資料では、mRNAがんワクチン・治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（がん治療用標準化MRNAワクチン、個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン）、用途...

世界のmRNAワクチン市場規模・現状・予測（2021年-2027年）

Global mRNA Vaccines Market Size, Status and Forecast 2021-2027
QYR2104Z3938 2021年4月 98Pages
QYResearch社発行の本調査資料では、mRNAワクチンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（開発中、前臨床、臨床I、臨床II）、用途別市場規模（新型コロナウイルス感染症、がん、感染症治療MRNAワクチン、感染予防MRNAワクチン...

世界のmRNA療法市場規模・現状・予測（2021年-2027年）

Global mRNA Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z3936 2021年4月 94Pages
QYResearch社発行の本調査資料では、mRNA療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ワクチン、治療薬）、用途別市場規模（mRNA標的化送達in vivo、遺伝子改変T細胞、癌免疫療法開発用ナノ粒子形質転換、小分子創薬）、主要...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年）

Global Acquired hemophilia A Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0029 2021年4月 97Pages
QYResearch社発行の本調査資料では、後天性血友病A治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0060 2021年4月 92Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界のMSD治療市場規模・現状・予測（2021年-2027年）

Global MSD Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3939 2021年4月 91Pages
QYResearch社発行の本調査資料では、MSD治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジ...

世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0096 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界の軟骨無形成症治療市場規模・現状・予測（2021年-2027年）

Global Achondroplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0013 2021年4月 92Pages
QYResearch社発行の本調査資料では、軟骨無形成症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（RBM-007、TA-46、B-701、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界のmRNA治療市場規模・現状・予測（2021年-2027年） By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for spec…
世界のmRNAワクチン市場規模・現状・予測（2021年-2027年） When the mRNA encoding the antigenic protein is injected into the human body, the antigenic protein can be synthesized in the body, thus causing the human immune response against the pathogen infection, namely the mRNA vaccine. In 2021, the global mRNA Vaccines market size will be US$ XX million and…
世界のmRNAがんワクチン・治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global mRNA Cancer Vaccines and Therapeutics Market The global mRNA Cancer Vaccines and Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and…
世界のmRNA療法市場規模・現状・予測（2021年-2027年） By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for spec…
世界の伝染病治療市場規模・現状・予測（2021年-2027年） In this report, we study the drugs for Communicable Diseases. Communicable diseases are disorders caused by organisms — such as bacteria, viruses,fungi or parasites Market Analysis and Insights: Global Treatment for Communicable Diseases Market The global Treatment for Communicable Diseases market s…